ATAI
Asset Logo

ATAI Life Sciences NV

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-26.77%
Annual Growth

3 years average annual growth

🌏

4
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.

📈 Performance

Price History*

-91.84%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$1.52

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in ATAI

4

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

14 weeks

💵 Average investment amount

$773

Last time a customer invested in ATAI

12 days
ATAI investor breakdown
💵 Income of investors

More than 200k

150k - 200k

25%

100k - 150k

50k - 100k

75%

Less than 50k

👶 Age of investors

18 - 25

25%

26 - 34

25%

35 - 90

50%
🙋 Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in ATAI also invest in...

Mind Medicine (MindMed) Inc

MNMD

📊 Share price

$7.09 USD
Find Out More

📊 Share price

$10.16 USD

🙌 Performance (5Yr p.a)

538.48%

📊 Share price

$146.67 USD

📈 HIGH PRICE GROWTH

📊 Share price

$4.45 USD

🙌 Performance (5Yr p.a)

-16.10%

📊 Share price

$2.59 USD

Want more shares? Try these...

📊 Share price

$25.35 USD

🙌 Performance (5Yr p.a)

-0.14%

📊 Share price

$5.71 USD
Compare
Add to watchlist